You are here

  • Home
  • Archive
  • Volume 6, Issue 7
  • European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease—the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood fl…

Article metrics

Article menu

Download PDFPDF

XML
Geriatric medicine
Protocol
European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease—the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201843378
Feb 201831237
Mar 2018514810
Apr 201837378
May 2018404010
Jun 201833316
Jul 201834349
Aug 2018413912
Sep 201827239
Oct 201846389
Nov 2018232313
Dec 201830309
Jan 201922207
Feb 2019383115
Mar 20197722
Apr 2019333311
May 2019241616
Jun 2019363211
Jul 2019181818
Aug 201919199
Oct 201922173
Nov 201926219
Dec 2019221914
Jan 2020332913
Feb 202012612
Mar 2020202011
May 20201587
Jun 2020956
Jul 2020151215
Aug 2020222012
Sep 202019105
Oct 2020322415
Nov 202025167
Dec 202015138
Jan 202113108
Feb 202110610
Mar 202135219
Apr 2021383017
May 2021252410
Jun 2021282812
Jul 202119198
Aug 202111117
Sep 202113139
Oct 2021403424
Nov 2021291922
Dec 202135159
Jan 202222186
Feb 2022212013
Mar 2022272823
Apr 2022161126
May 2022191317
Jun 2022272411
Jul 2022242011
Aug 2022211711
Sep 2022339
Oct 2022777
Nov 20221687
Dec 2022231810
Jan 2023242010
Feb 202316145
Mar 2023342717
Apr 2023211511
May 202316810
Jun 2023753
Jul 2023171316
Aug 202313119
Sep 2023773
Oct 202317154
Nov 2023472213
Dec 202333257
Jan 202415114
Feb 202420208
Mar 20242718123
Apr 20249928
Total17651456923